Literature DB >> 23916892

Point-of-care tests for infection control: should rapid testing be in the laboratory or at the front line?

C Moore1.   

Abstract

BACKGROUND: A point-of-care test (POCT) offers a rapid result to manage a patient immediately. The presumed simplicity of such tests belies observed variation between personnel in performing and interpreting results when not appropriately trained. The number of point-of-care devices being developed for the diagnosis of infectious diseases is increasing; by understanding the limitations associated with their use, such tests for infection control purposes may be possible. AIM: To review the expanding repertoire of POCTs for the diagnosis of infectious diseases and to assess their utility as tools to aid in the reduction of hospital-acquired infection and outbreak management.
METHODS: A systematic review using PubMed and Scopus of published literature on the subject of POCTs for the diagnosis of infectious diseases.
FINDINGS: Although the number of publications describing POCTs is increasing, there remains a paucity of literature describing their use in a clinical setting. Of the literature reviewed, POCTs for the diagnosis of respiratory syncytial virus and norovirus have the greatest utility in an infection control setting, although the data suggest that sensitivity and training issues might be a problem. The future generation of POCT devices is likely to be molecular-based, improving sensitivity but at a significant cost to the user.
CONCLUSIONS: POCTs have a role in infection control but currently the lack of good, consistent clinical data surrounding their use outside of the laboratory is a limiting factor in their implementation.
© 2013 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Infection control; Influenza; Norovirus; Rapid test; Respiratory syncytial virus

Mesh:

Year:  2013        PMID: 23916892     DOI: 10.1016/j.jhin.2013.06.005

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  15 in total

1.  Surface-enhanced Raman spectroscopy competitive binding biosensor development utilizing surface modification of silver nanocubes and a citrulline aptamer.

Authors:  Brian M Walton; George W Jackson; Nicolaas Deutz; Gerard Cote
Journal:  J Biomed Opt       Date:  2017-07-01       Impact factor: 3.170

2.  Characterization of cross-reactive norovirus-specific monoclonal antibodies.

Authors:  Baijun Kou; Sue E Crawford; Nadim J Ajami; Rita Czakó; Frederick H Neill; Tomoyuki N Tanaka; Noritoshi Kitamoto; Timothy G Palzkill; Mary K Estes; Robert L Atmar
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

Review 3.  The Point-of-Care Laboratory in Clinical Microbiology.

Authors:  Michel Drancourt; Audrey Michel-Lepage; Sylvie Boyer; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

4.  Occult HBV Infection in Nigeria.

Authors:  O A Akintule; B A Olusola; G N Odaibo; D O Olaleye
Journal:  Arch Basic Appl Med       Date:  2018-05-04

5.  Human Immunodeficiency Virus (HIV)-Infected Patients Accept Finger Stick Blood Collection for Point-Of-Care CD4 Testing.

Authors:  Géraldine Daneau; Natasha Gous; Lesley Scott; Joachim Potgieter; Luc Kestens; Wendy Stevens
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

6.  Identification and Characterization of Single-Chain Antibodies that Specifically Bind GI Noroviruses.

Authors:  Amy M Hurwitz; Wanzhi Huang; Baijun Kou; Mary K Estes; Robert L Atmar; Timothy Palzkill
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

7.  Equivalent Performance of the Cobas® Cdiff Test for Use on the Cobas® Liat® System and the Cobas® 4800 System.

Authors:  Sachin K Garg; Kyle Lu; John Duncan; Lance R Peterson; Oliver Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-12-05

8.  Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.

Authors:  Zibusiso Ndlovu; Emmanuel Fajardo; Elton Mbofana; Tatenda Maparo; Daniela Garone; Carol Metcalf; Helen Bygrave; Kekeletso Kao; Sekesai Zinyowera
Journal:  PLoS One       Date:  2018-03-02       Impact factor: 3.240

9.  Quantitative influenza follow-up testing (QIFT)--a novel biomarker for the monitoring of disease activity at the point-of-care.

Authors:  Xi Chen; Kaveh Pouran Yousef; Susanne Duwe; Katharina Karsch; Sandeep Grover; Stephanie Wählisch; Patrick Obermeier; Franziska Tief; Susann Mühlhans; Lea Seeber; Max von Kleist; Brunhilde Schweiger; Barbara Rath
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

10.  Point-of-Care Testing for Clostridium Difficile Infection: A Real-World Feasibility Study of a Rapid Molecular Test in Two Hospital Settings.

Authors:  Simon D Goldenberg; Karen N Bisnauthsing; Amita Patel; Anne Postulka; Duncan Wyncoll; Rebekah Schiff; Gary L French
Journal:  Infect Dis Ther       Date:  2014-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.